By Sheeba M. | April 15, 2026
Cannabis Banking Reform Stalls Again: What It Means for MSO Valuations
The cannabis industry’slongstanding banking reform bill, the SAFE Banking Act, has once again failed to advance in Congress — marking another setback for an industry desperate for access to traditional financial services. For investors, the implications are significant: multi-state operators (MSOs) remain forced to operate largely in cash, creating operational risks, regulatory burdens, and a valuation discount that has persisted for years.
The Cash Problem Is Worse Than It Looks
Running a cannabis business in cash isn’t just inconvenient — it’s expensive. Dispensaries become de facto vaults, requiring armored car services for deposits, higher insurance premiums, and increased exposure to theft. According to industry estimates, banking-related compliance costs add 5-10% to operational expenses for the average MSO.
This creates a structural disadvantage that Canadian cannabis companies — which operate under federal legalization — simply don’t face. CURLF, GTIF, and other U.S.-listed operators consistently trade at lower price-to-sales multiples than their Toronto-listed counterparts despite serving larger markets.
Valuation Gap Widens
The lack of banking access is a key reason institutional investors — pension funds, family offices, and traditional hedge funds — remain largely absent from U.S. cannabis equities. Without banking, these firms face reputational risk and regulatory complications in handling cannabis-adjacent investments.
The result is a retail-dominated shareholder base that lacks the staying power to support higher valuations. Until federal banking reform passes, expect GTIF and similar names to continue trading 30-50% below their fundamental intrinsic values based on cash flow metrics.
State-Level Wins Don’t Fix Federal Problem
Several states — including New York, New Jersey, and Illinois — have established robust adult-use programs, and VRNOF has emerged as a regional leader in the Northeast corridor. But state-level success doesn’t solve the federal banking issue. Operators in legalized states still face the same cash-handling restrictions when dealing with other state-licensed businesses.
The industry’s hope now rests on comprehensive reform in 2027, though political observers remain skeptical of any major cannabis legislation passing a divided Congress in an election year.
What Smart Money Is Doing
Despite the headwinds, institutional interest in cannabis is quietly building. Several large MSOs have restructured their balance sheets to reduce debt and extend runway, positioning themselves to capitalize when reform eventually arrives. CURLF recently raised $85 million in an equity offering at a significant premium to its market price — a signal that sophisticated investors see value here.
For long-term investors, the current discount may represent a rare entry point. The question isn’t whether reform will come — it’s whether you can stomach the wait.
Bottom Line
The SAFE Banking Act’s stalling is frustrating but not surprising. Cannabis reform has always been a slow burn. In the meantime, investors should focus on operators with strong balance sheets, diversified state presence, and disciplined cost controls. GTIF, CURLF, and VRNOF remain the names to watch.
Sources
- Marijuana Moment — Senate SAFE Banking vote coverage
- SEC Filings — CURLF, GTIF quarterly reports
- Leafly — State-by-state market analysis
Track cannabis stocks with the Weedstock Real-Time Tracker